Seroprevalence of the Serological Markers of Transfusion-Transmissible Infections among Volunteer Blood Donors of Kosti Obstetrics and Gynecology Hospital

Background: Transfusion-transmissible infections are well-known global health challenges. The present study is proposed to investigate the seropositivity of anti-HIV1/2, anti-HCV, HBsAg, and anti-<i>T.pallidum</i> among volunteer blood donors of Kosti Obstetrics and Gynecology Hospital....

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Babiker Saad Almugadam, Omer Mohammed Ali Ibrahim, Yousif Mousa Alobaid Ahmed
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
R
Acceso en línea:https://doaj.org/article/971f718f49ac41de9ecaae76c02cb3b2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:971f718f49ac41de9ecaae76c02cb3b2
record_format dspace
spelling oai:doaj.org-article:971f718f49ac41de9ecaae76c02cb3b22021-11-25T18:19:19ZSeroprevalence of the Serological Markers of Transfusion-Transmissible Infections among Volunteer Blood Donors of Kosti Obstetrics and Gynecology Hospital10.3390/medicines81100642305-6320https://doaj.org/article/971f718f49ac41de9ecaae76c02cb3b22021-10-01T00:00:00Zhttps://www.mdpi.com/2305-6320/8/11/64https://doaj.org/toc/2305-6320Background: Transfusion-transmissible infections are well-known global health challenges. The present study is proposed to investigate the seropositivity of anti-HIV1/2, anti-HCV, HBsAg, and anti-<i>T.pallidum</i> among volunteer blood donors of Kosti Obstetrics and Gynecology Hospital. Methods: Our study was conducted in a cross-sectional retrospective manner. The data of donors who attended Kosti Obstetrics and Gynecology Hospital throughout 2016 to 2018 were reviewed and retrieved manually from blood bank records. Results: Out of 8139 donors, 22.52% were seropositive for serological markers of TTIs and 1.67% were seropositive for at least two serological markers of TTIs. The overall seropositivity rate of anti-HIV1/2, HBsAg, anti-HCV, and anti-<i>T.pallidum</i> was 1.77%, 6.07%, 1.14%, and 11.87%, respectively (<i>p</i> < 0.000). Anti-<i>T.pallidum</i> was the most frequently detected (<i>p</i> < 0.05) marker across all study variables. TTIs seroprevalence was significantly (<i>p</i> < 0.05) varied according to the age, residence, occupations, and blood groups. Notably, there was a rising trend in the rate of anti-HIV1/2 and seropositivity for more than one marker with age (<i>p</i> < 0.000). Regionally, rural area residents had a higher rate of anti-HIV1/2 (2.20%), HBsAg (6.31%), anti-HCV (1.42%), anti-<i>T.pallidum</i> (18.38%), and multiple markers seropositivity (2.28%) compared to urban areas. Between occupations, the highest rate of anti-HIV1/2 (<i>p</i> = 0.483), HBsAg (<i>p</i> = 0.003), anti-HCV (<i>p</i> = 0.408), anti-<i>T.pallidum</i> (<i>p</i> < 0.000), and multiple markers seropositivity (<i>p</i> < 0.000) were detected in farmers. Regarding the screening, we also found that the frequency of anti-<i>T.pallidum</i> was significantly (<i>p</i> = 0.003) higher in donors who carry the AB+ve blood group, whereas anti-HCV (1.83%) was more frequent in donors carry O−ve blood group (<i>p</i> = 0.255). As seen, anti-<i>T.pallidum</i>+HBsAg was the most frequently (1.22%) co-occurring markers. In contrast, anti-<i>T.pallidum</i>+anti-HIV1/2+HBsAg was the lowest frequency one (<i>p</i> < 0.000). Conclusions: The study showed an alarming rate of TTIs, which suggests the requirement for comprehensive surveillance and health education programs.Babiker Saad AlmugadamOmer Mohammed Ali IbrahimYousif Mousa Alobaid AhmedMDPI AGarticleanti-HIV1/2anti-HCVanti-<i>T.pallidum</i>HBsAgTTIsMedicineRENMedicines, Vol 8, Iss 64, p 64 (2021)
institution DOAJ
collection DOAJ
language EN
topic anti-HIV1/2
anti-HCV
anti-<i>T.pallidum</i>
HBsAg
TTIs
Medicine
R
spellingShingle anti-HIV1/2
anti-HCV
anti-<i>T.pallidum</i>
HBsAg
TTIs
Medicine
R
Babiker Saad Almugadam
Omer Mohammed Ali Ibrahim
Yousif Mousa Alobaid Ahmed
Seroprevalence of the Serological Markers of Transfusion-Transmissible Infections among Volunteer Blood Donors of Kosti Obstetrics and Gynecology Hospital
description Background: Transfusion-transmissible infections are well-known global health challenges. The present study is proposed to investigate the seropositivity of anti-HIV1/2, anti-HCV, HBsAg, and anti-<i>T.pallidum</i> among volunteer blood donors of Kosti Obstetrics and Gynecology Hospital. Methods: Our study was conducted in a cross-sectional retrospective manner. The data of donors who attended Kosti Obstetrics and Gynecology Hospital throughout 2016 to 2018 were reviewed and retrieved manually from blood bank records. Results: Out of 8139 donors, 22.52% were seropositive for serological markers of TTIs and 1.67% were seropositive for at least two serological markers of TTIs. The overall seropositivity rate of anti-HIV1/2, HBsAg, anti-HCV, and anti-<i>T.pallidum</i> was 1.77%, 6.07%, 1.14%, and 11.87%, respectively (<i>p</i> < 0.000). Anti-<i>T.pallidum</i> was the most frequently detected (<i>p</i> < 0.05) marker across all study variables. TTIs seroprevalence was significantly (<i>p</i> < 0.05) varied according to the age, residence, occupations, and blood groups. Notably, there was a rising trend in the rate of anti-HIV1/2 and seropositivity for more than one marker with age (<i>p</i> < 0.000). Regionally, rural area residents had a higher rate of anti-HIV1/2 (2.20%), HBsAg (6.31%), anti-HCV (1.42%), anti-<i>T.pallidum</i> (18.38%), and multiple markers seropositivity (2.28%) compared to urban areas. Between occupations, the highest rate of anti-HIV1/2 (<i>p</i> = 0.483), HBsAg (<i>p</i> = 0.003), anti-HCV (<i>p</i> = 0.408), anti-<i>T.pallidum</i> (<i>p</i> < 0.000), and multiple markers seropositivity (<i>p</i> < 0.000) were detected in farmers. Regarding the screening, we also found that the frequency of anti-<i>T.pallidum</i> was significantly (<i>p</i> = 0.003) higher in donors who carry the AB+ve blood group, whereas anti-HCV (1.83%) was more frequent in donors carry O−ve blood group (<i>p</i> = 0.255). As seen, anti-<i>T.pallidum</i>+HBsAg was the most frequently (1.22%) co-occurring markers. In contrast, anti-<i>T.pallidum</i>+anti-HIV1/2+HBsAg was the lowest frequency one (<i>p</i> < 0.000). Conclusions: The study showed an alarming rate of TTIs, which suggests the requirement for comprehensive surveillance and health education programs.
format article
author Babiker Saad Almugadam
Omer Mohammed Ali Ibrahim
Yousif Mousa Alobaid Ahmed
author_facet Babiker Saad Almugadam
Omer Mohammed Ali Ibrahim
Yousif Mousa Alobaid Ahmed
author_sort Babiker Saad Almugadam
title Seroprevalence of the Serological Markers of Transfusion-Transmissible Infections among Volunteer Blood Donors of Kosti Obstetrics and Gynecology Hospital
title_short Seroprevalence of the Serological Markers of Transfusion-Transmissible Infections among Volunteer Blood Donors of Kosti Obstetrics and Gynecology Hospital
title_full Seroprevalence of the Serological Markers of Transfusion-Transmissible Infections among Volunteer Blood Donors of Kosti Obstetrics and Gynecology Hospital
title_fullStr Seroprevalence of the Serological Markers of Transfusion-Transmissible Infections among Volunteer Blood Donors of Kosti Obstetrics and Gynecology Hospital
title_full_unstemmed Seroprevalence of the Serological Markers of Transfusion-Transmissible Infections among Volunteer Blood Donors of Kosti Obstetrics and Gynecology Hospital
title_sort seroprevalence of the serological markers of transfusion-transmissible infections among volunteer blood donors of kosti obstetrics and gynecology hospital
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/971f718f49ac41de9ecaae76c02cb3b2
work_keys_str_mv AT babikersaadalmugadam seroprevalenceoftheserologicalmarkersoftransfusiontransmissibleinfectionsamongvolunteerblooddonorsofkostiobstetricsandgynecologyhospital
AT omermohammedaliibrahim seroprevalenceoftheserologicalmarkersoftransfusiontransmissibleinfectionsamongvolunteerblooddonorsofkostiobstetricsandgynecologyhospital
AT yousifmousaalobaidahmed seroprevalenceoftheserologicalmarkersoftransfusiontransmissibleinfectionsamongvolunteerblooddonorsofkostiobstetricsandgynecologyhospital
_version_ 1718411333651660800